Abstract
Expression of the breast and ovarian cancer gene BRCA1 is regulated at both the transcriptional and post-transcriptional levels. We found that the expression of the BRCA1 protein may also be regulated at the translational level. In addition to an AUG start codon at position 1, BRCA1 mRNA has a second in-frame AUG (+17) that acts as an alternative start codon to generate a novel BRCA1 protein that lacks the first 17 amino acids (ΔBRCA1(17aa)). We fused cDNAs encoding the second exon of BRCA1 of the wild-type BRCA1 gene (wt-BRCA1) and a mutated BRCA1 gene (mt-BRCA1), in which the first initiation site and its Kozak consensus sequence were abolished, with the nucleophosmin (NPM) reporter gene and used them for in vitro and in vivo translation assays. In both systems, the wt-BRCA1-NPM constructs produced two distinct proteins (18 and 16 kD) begun from the first and second AUGs. The mt-BRCA1-NPM constructs produced only the shorter 16-kD protein lacking the first 17 amino acids of the BRCA1 gene. Next, we analysed the N-terminal protein sequence of purified BRCA1 protein from normal thymocytes and found two different BRCA1 proteins, derived from translation of the first and second in-frame AUGs. Thus, BRCA1 protein expression can be regulated at the translation level in normal cells. Characterization of ΔBRCA1(17aa) may shed light on the function and regulation of BRCA1 in normal cells as well as the pathogenesis of breast and ovarian cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF and Koonin EV . 1997 FASEB J 11: 68–76
Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D and Solomon E . 1996 Oncogene 12: 2507–2513
Callebaut I and Mornon JP . 1997 FEBS Lett 400: 25–30
Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC et al. 1994 Nat Genet 8: 387–391
Catteau A, Harris WH, Xu CF and Solomon E . 1999 Oncogene 18: 1957–1965
Chai YL, Cui J, Shao N, Shyam E, Reddy P and Rao VN . 1999 Oncogene 18: 263–268
Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA and Chan PK . 1989 Biochemistry 28: 1033–1039
Chapman MS and Verma IM . 1996 Nature 382: 678–679
Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL and Lee WH . 1996 Cancer Res 56: 3168–3172
Colizan JE, Dun BM, Ploegh HL, Speicher DW and Wingfield PT . Curr Protocols Pro Sci New York
Cortez D, Wang Y, Qin J and Elledge SJ . 1999 Science 286: 1162–1166
Cressman VL, Backlund DC, Hicks EM, Gowen LC, Godfrey, V and Koller BH . 1999 Cell Growth Differ 10: 1–10
Cui JQ, Shao N, Chai Y, Wang H, Reddy ES and Rao VN . 1998 Oncol Rep 5: 591–595
Dobrovic A and Simpfendorfer D . 1997 Cancer Res 57: 3347–3350
Easton DF, Bishop DT, Ford D and Crockford GP . 1993 Am J Hum Genet 52: 678–701
Ford D, Easton DF, Bishop DT, Narod SA and Goldgar DE . 1994 Lancet 343: 692–695
Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE and King MC . 1994 Nat Genet 8: 399–404
Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM and Dalla-Favera R . 1991 Proc Natl Acad Sci USA 88: 5413–5417
Haile DT and Parvin JD . 1999 J Biol Chem 274: 2113–2117
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B and King MC . 1990 Science 250: 1684–1689
Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J and Knowles DM . 1994 Blood 83: 3581–3590
Irminger-Finger I, Siegel BD and Leung WC . 1999 Biol Chem 380: 117–128
Irminger-Finger I, Soriano JV, Vaudan G, Montesano R and Sappino AP . 1998 J Cell Biol 143: 1329–1339
Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC and Rauscher FJR . 1998 Oncogene 16: 1097–1112
Jin Y, Xu XL, Yang MC, Wei F, Ayi TC, Bowcock AM and Baer R . 1997 Proc Natl Acad Sci USA 94: 12075–12080
Kleiman FE and Manley JL . 1999 Science 285: 1576–1579
Lee WY, Jin YT, Chang TW, Lin PW and Su IJ . 1999 Histopathology 34: 106–112
Lu M, Conzen SD, Cole CN and Arrick BA . 1996 Cancer Res 56: 4578–4581
Magdinier F, Ribieras S, Lenoir GM, Frappart L and Dante R . 1998 Oncogene 17: 3169–3176
Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W and Archer TK . 1998 Oncogene 16: 1161–1169
Matsudaira P . 1987 J Biol Chem 262: 10035–10038
Meza JE, Brzovic PS, King MC and Klevit RE . 1999 J Biol Chem 274: 5659–5665
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. 1994 Science 266: 66–71
Monteiro AN, August A and Hanafusa H . 1996 Proc Natl Acad Sci USA 93: 13595–13599
Ouchi T, Monteiro AN, August A, Aaronson SA and Hanafusa H . 1998 Proc Natl Acad Sci USA 95: 2302–2306
Pao GM, Janknecht R, Ruffner H, Hunter T and Verma IM . 2000 Proc Natl Acad Sci USA 97: 1020–1025
Ruffner H and Verma IM . 1997 Proc Natl Acad Sci USA 94: 7138–7143
Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM and Parvin JD . 1997a Proc Natl Acad Sci USA 94: 5605–5610
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T and Livingston DM . 1997b Cell 88: 265–275
Thakur S and Croce CM . 1999 J Biol Chem 274: 8837–8843
Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB and Weber BL . 1997 Mol Cell Biol 17: 444–452
Thomas JE, Smith M, Tonkinson JL, Rubinfeld B and Polakis P . 1997 Cell Growth Differ 8: 801–809
Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT . 1995 Nat Genet 9: 444–450
Wang H, Shao N, Ding QM, Cui J, Reddy ES and Rao VN . 1997 Oncogene 15: 143–157
Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ and Slamon DJ . 1999 Nat Genet 21: 236–240
Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM and Baer R . 1996 Nat Genet 14: 430–440
Xu CF, Brown MA, Chambers JA, Griffiths B, Nicolai H and Solomon E . 1995 Hum Mol Genet 4: 2259–2264
Xu CF, Brown MA, Nicolai H, Chambers JA, Griffiths BL and Solomon E . 1997a Hum Mol Genet 6: 1057–1062
Xu CF, Chambers JA and Solomon E . 1997b J Biol Chem 272: 20994–20997
Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A and Deng CX . 1999 Nat Genet 22: 37–43
Yarden RI and Brody LC . 1999 Proc Natl Acad Sci USA 96: 4983–4988
Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL and El-Deiry WS . 1998 Oncogene 16: 1713–1721
Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD and Lee WH . 1999 Science 285: 747–750
Acknowledgements
G Prolla was partially supported by training grant CA-2T32CA09454 from the National Cancer Institute. This work was also supported in part by grant NIH R21-CA66229.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, J., Prolla, G., Rostagno, A. et al. Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein ΔBRCA1(17aa). Oncogene 19, 2767–2773 (2000). https://doi.org/10.1038/sj.onc.1203599
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203599
Keywords
This article is cited by
-
Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells
Molecular Cancer (2010)
-
Transcription pattern of UL131A-128 mRNA in clinical strains of human cytomegalovirus
Journal of Biosciences (2010)
-
Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer
Oncogene (2003)
-
Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1
Oncogene (2003)
-
A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency
Oncogene (2001)